Portal de Periódicos da CAPES

Plantar exfoliation and desquamation during efalizumab therapy

2007; Wiley; Volume: 22; Issue: 5 Linguagem: Inglês

10.1111/j.1468-3083.2007.02414.x

1468-3083

Esra Adışen, MA Gürer,

Toxin Mechanisms and Immunotoxins

Journal of the European Academy of Dermatology and VenereologyVolume 22, Issue 5 p. 633-634 Plantar exfoliation and desquamation during efalizumab therapy E Adíşen, Corresponding Author E Adíşen *Corresponding author, Gazi University Faculty of Medicine, Department of Dermatology, 06500 Beşevler, Ankara, Turkey, tel. +90 312202 61 29; fax +90 312212 90 18; E-mail: [email protected]Search for more papers by this authorMA Gürer, MA Gürer Gazi University Faculty of Medicine, Department of Dermatology, Ankara, TurkeySearch for more papers by this author E Adíşen, Corresponding Author E Adíşen *Corresponding author, Gazi University Faculty of Medicine, Department of Dermatology, 06500 Beşevler, Ankara, Turkey, tel. +90 312202 61 29; fax +90 312212 90 18; E-mail: [email protected]Search for more papers by this authorMA Gürer, MA Gürer Gazi University Faculty of Medicine, Department of Dermatology, Ankara, TurkeySearch for more papers by this author First published: 06 August 2007 https://doi.org/10.1111/j.1468-3083.2007.02414.xCitations: 4 DOI: 10.1111/j.1468-3083.2007.02414.x Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Sterry W, Stingl G, Langley RG et al .; CLEAR Multinational Study Group. CLEAR Multinational Study Group. Clinical Experience Acquired with Raptiva (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo-controlled trial. J Dtsch Dermatol Ges 2006; 4: 947–956. 10.1111/j.1610-0387.2006.06111.x CASPubMedGoogle Scholar 2 Papp KA, Camisa C, Stone SP et al . Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis: review of clinical data. Part II. J Cutan Med Surg 2005; 9: 313–323. 10.1007/s10227-005-0117-0 PubMedWeb of Science®Google Scholar 3 Papp KA, Ho V, Langley R et al . Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis. J Cutan Med Surg 2006; 9: 26–32. 10.1007/s10227-006-0104-0 PubMedWeb of Science®Google Scholar 4 Wyatt AJ, Leonard GD, Sachs DL. Cutaneous reactions to chemotherapy and their management. Am J Clin Dermatol 2006; 7: 45–63. 10.2165/00128071-200607010-00005 PubMedWeb of Science®Google Scholar 5 Webster-Gandy JD, How C, Harrold K. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre. Eur J Oncol Nurs 2007; 8; 238–246. 10.1016/j.ejon.2006.10.004 Web of Science®Google Scholar 6 Wilkes GM, Doyle D. Palmar-plantar erythrodysesthesia. Clin J Oncol Nurs 2005; 9: 103–106. 10.1188/05.CJON.103-106 PubMedGoogle Scholar 7 Shiohara T, Mizukawa Y, Teraki Y. Pathophysiology of fix drug eruption: the role of skin-resident T cells. Curr Opin Allergy Clin Immunol 2002; 2: 317–323. 10.1097/00130832-200208000-00005 PubMedGoogle Scholar 8 Shiohara T, Nicoloff BG, Sagawa Y et al . Fix drug eruption. Expression of epidermal keratinocyte intercellular adhesion molecule-1 (ICAM-1). Arc Dermatol 1989; 125: 1371–1376. PubMedWeb of Science®Google Scholar 9 Mizukawa Y, Yamazaki Y, Teraki Y et al . Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption. Am J Pathol 2002; 161: 1337–1347. 10.1016/S0002-9440(10)64410-0 CASPubMedWeb of Science®Google Scholar Citing Literature Volume22, Issue5May 2008Pages 633-634 ReferencesRelatedInformation